Aimmune Therapeutics
Why Robinhood?
You can watch AIMT and buy or sell other stocks, ETFs, and their options commission-free!About AIMT
Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system.
AIMT Key Statistics
Stock Snapshot
Aimmune Therapeutics(AIMT) stock is priced at $34.49, giving the company a market capitalization of 2.26B. It carries a P/E multiple of -7.68.
On 2026-02-20, Aimmune Therapeutics(AIMT) stock opened at —, reached a high of —, and a low of —.
Aimmune Therapeutics(AIMT) shares are trading with a volume of 0, against a daily average of 1.45M.
In the last year, Aimmune Therapeutics(AIMT) shares hit a 52-week high of $37.00 and a 52-week low of $10.09.
In the last year, Aimmune Therapeutics(AIMT) shares hit a 52-week high of $37.00 and a 52-week low of $10.09.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.